JOHN MENDLEIN - 11 Jan 2023 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Director
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
11 Jan 2023
Net transactions value
+$698,138
Form type
4
Filing time
13 Jan 2023, 17:20:08 UTC
Previous filing
13 Jun 2022
Next filing
20 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Purchase $499,232 +88,048 +56% $5.67 246,139 11 Jan 2023 Direct
transaction FATE Common Stock Purchase $198,906 +36,631 +15% $5.43 282,770 13 Jan 2023 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.